Esophagus

Papers
(The TQCC of Esophagus is 5. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
Biased expression of mutant alleles in cancer-related genes in esophageal squamous cell carcinoma116
Real-world treatment patterns and outcomes in Japanese patients with cervical esophageal cancer44
Effect of chemoradiation on the development of second primary cancers after endoscopic resection of T1 esophageal squamous cell carcinoma41
Dynorphin participates in interaction between depression and non-erosive reflux disease37
Pre-existing and new-onset depression among patients undergoing esophageal cancer surgery: a nationwide cohort study in South Korea25
Esophageal motility disorders missed during endoscopy23
Peroral endoscopic myotomy is equally safe and highly effective treatment option in achalasia patients with both lower and higher ASA classification status23
Significance of lymphovascular invasion in esophageal squamous cell carcinoma undergoing neoadjuvant chemotherapy followed by esophagectomy20
Clinical predictors of special type of esophageal cancer18
Five-year follow-up of nivolumab treatment in Japanese patients with esophageal squamous-cell carcinoma (ATTRACTION-1/ONO-4538-07)18
A simpler diagnostic algorithm of the Japan Esophageal Society classification for Barrett’s esophagus-related superficial neoplasia17
Clinical usefulness of sputum culture on the first postoperative day to predict early postoperative pneumonia after esophagectomy for esophageal cancer15
Maximum standardized uptake value change rate before and after neoadjuvant chemotherapy can predict early recurrence in patients with locally advanced esophageal cancer: a multi-institutional cohort s13
Early detection of anastomotic leakage after esophagectomy using drain amylase levels13
Multicenter phase II study of trifluridine/tipiracil for esophageal squamous carcinoma refractory/intolerant to 5-fluorouracil, platinum compounds, and taxanes: the ECTAS study12
Impact of pulmonary vein anatomy and left atrial size on postoperative atrial fibrillation after esophagectomy for esophageal cancer12
Reply to: The use of drugs to prevent postoperative delirium in elderly patients with radical esophagectomy12
Advancing high-resolution manometry: evaluating the use of multiple rapid swallows versus apple viscous swallows in clinical practice12
Usefulness of wearable fitness tracking devices in patients undergoing esophagectomy12
Endoscopic findings suggestive of a high risk of non-radical cure after definitive chemoradiotherapy for cT1bN0M0 esophageal squamous cell carcinoma12
The characteristics and prognostic significance of esophageal squamous cell carcinoma with synchronous multiple lesions: over 10-year experience12
The impact of weight loss during neoadjuvant chemotherapy on postoperative infectious complications and prognosis in patients with esophageal cancer: exploratory analysis of OGSG100312
Role of modified Glasgow Prognostic Score in patients with achalasia who underwent laparoscopic Heller-myotomy with Dor-fundoplication12
Achalasia: laparoscopic Heller myotomy with fundoplication versus peroral endoscopic myotomy—a systematic review and meta-analysis11
Risk stratification for synchronous/metachronous recurrence after endoscopic submucosal dissection for Barrett’s esophageal adenocarcinoma using the length of Barrett’s esophagus11
Preoperative docetaxel, cisplatin, and 5-fluorouracil for resectable locally advanced esophageal and esophagogastric junctional adenocarcinoma11
Early versus delayed surgery following neoadjuvant chemoradiation for esophageal cancer: a systematic review and meta-analysis10
Changes in and clinical utility of maximum phonation time and repetitive saliva swallowing test scores after esophagectomy10
Impact of preoperative 6-minute walk distance on long-term prognosis after esophagectomy in patients with esophageal cancer10
Survival impact of perioperative changes in prognostic nutritional index levels after esophagectomy10
Is it meaningful to add mesh reinforcement to laparoscopic fundoplication for esophageal hiatal hernias in the patients with high risk of hiatal hernia recurrence?10
High rate of missed Barrett’s esophagus when screening with forceps biopsies9
Usefulness of the preoperative inflammation-based prognostic score and the ratio of visceral fat area to psoas muscle area on predicting survival for surgically resected adenocarcinoma of the esophago9
Endoscopic imaging modalities for diagnosing the invasion depth of superficial esophageal squamous cell carcinoma: a systematic review9
Response to chemotherapy could predict the prognosis of esophageal squamous cell carcinoma treated with neoadjuvant docetaxel, cisplatin, and fluorouracil (DCF) followed by surgery: long-term results 9
Saliva secretion is reduced in proton pump inhibitor-responsive non-erosive reflux disease patients9
Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-38
First-line nivolumab plus ipilimumab or chemotherapy versus chemotherapy alone in advanced esophageal squamous cell carcinoma: a Japanese subgroup analysis of open-label, phase 3 trial (CheckMate 648/8
Surgical treatment of esophageal cancer with anomaly of the aortic arch and its branches8
Esophageal cancer patients' survival after complete response to definitive chemoradiotherapy: a retrospective analysis8
Distal esophageal wall thickness correlates with dysphagia in adult patients with eosinophilic esophagitis8
Impact of taxanes after PD-1 blockade exposure in advanced esophageal squamous cell carcinoma8
First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study8
An anti-alcoholism drug, disulfiram and copper complex improves radio-resistance of tumor-initiating cells in esophageal squamous cell carcinoma8
Multicenter retrospective analysis of complications and risk factors in endoscopic resection for esophageal cancer across Japan8
Esophageal cancer practice guidelines 2022 edited by the Japan esophageal society: part 17
Stepwise innovation of anesthesia through endotracheal intubation during esophagectomy for cancer7
Effectiveness of prehabilitation during neoadjuvant therapy for patients with esophageal or gastroesophageal junction cancer: a systematic review7
Tumor response and survival outcomes of salvage concurrent chemoradiotherapy with three-dimensional conformal radiotherapy and 5-fluorouracil/platinum-based chemotherapy for postoperative locoregional7
A nationwide survey on the safety of cricothyrotomy: a multicenter retrospective study in Japan7
Second-line pembrolizumab versus chemotherapy in Japanese patients with advanced esophageal cancer: subgroup analysis from KEYNOTE-1817
Two onset types of achalasia and the long-term course to diagnosis7
Outcome research on esophagectomy analyzed using nationwide databases in Japan: evidences generated from real-world data7
Is oropharyngoesophageal scintigraphy the method of choice for assessing dysphagia in systemic sclerosis? A single center experience6
Correlation between TXNRD1/HO-1 expression and response to neoadjuvant chemoradiation therapy in patients with esophageal squamous cell carcinoma6
Modification of the lesser curvature incision line enhanced gastric conduit perfusion as determined by indocyanine green fluorescence imaging and decreased the incidence of anastomotic leakage followi6
Genomic analyses reveal SCN7A is associated with the prognosis of esophageal squamous cell carcinoma6
Risk factors and prognosis for esophageal fistula in patients with esophageal squamous cell carcinoma during radiotherapy6
Type B2 vessels and infiltrative growth patterns b and c are associated with lymphatic invasion in pT1a-lamina propria mucosa esophageal squamous cell carcinoma6
Betulin gel alleviates esophageal stricture following endoscopic submucosal dissection: an animal study6
Celebrating 20 years of “Esophagus”5
Esophageal replacement when stomach conduit is unavailable: is colon the best option?5
Clinical predictors of early postoperative recurrence after radical esophagectomy for thoracic esophageal cancer5
A message from the new editor-in-chief 20245
Efficacy and survival of nivolumab treatment for recurrent/unresectable esophageal squamous-cell carcinoma: real-world clinical data from a large multi-institutional cohort5
Refining postoperative monitoring of recurrent laryngeal nerve injury in esophagectomy patients through transcutaneous laryngeal ultrasonography5
Novel endoscopic approaches using the endocytoscopy for the target biopsy in esophageal eosinophilia5
Efficacy of laparoscopic fundoplication in patients with chronic cough and gastro-oesophageal reflux5
The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma5
Long-term results after laparoscopic revision fundoplication: a retrospective, single-center analysis in 194 patients with recurrent hiatal hernia5
Efficacy of thoracic endovascular aortic repair for aorto-esophageal fistula due to esophageal cancer: a systematic review and meta-analysis5
Usefulness of prone-position computed tomography as preoperative simulation prior to thoracoscopic esophagectomy for thoracic esophageal cancer5
Fundoplication versus oral proton pump inhibitors for gastroesophageal reflux disease: a systematic review and meta-analysis of randomized clinical trials5
Histological changes in the human esophagus following triamcinolone injection to prevent esophageal stricture after endoscopic submucosal dissection5
Phase II study of BKM120 in patients with advanced esophageal squamous cell carcinoma (EPOC1303)5
In females, salivary secretion was significantly lower in patients with severe reflux esophagitis than in healthy controls5
Early intervention of the perioperative multidisciplinary team approach decreases the adverse events during neoadjuvant chemotherapy for esophageal cancer patients5
0.036932945251465